Jussi P. Lehtonen

Pl 100
Tampere, 33014, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Coxsackievirus B Infections Are Associated With the Risk of Islet Autoimmunity in Children With Strong Genetic Susceptibility to Type 1 Diabetes-Results From the TRIGR Divia Study.

Coxsackievirus B Infections Are Associated With the Risk of Islet Autoimmunity in Children With Strong Genetic Susceptibility to Type 1 Diabetes-Results From the TRIGR Divia Study.

Journal: Diabetes/metabolism research and reviews

Published: February 10, 2026

Marine n-3 Long-Chain Polyunsaturated Fatty Acid Intake in Pregnancy and Risk of Early Life Infections in 3 Nordic Cohorts: A HEDIMED Consortium Study.

Marine n-3 Long-Chain Polyunsaturated Fatty Acid Intake in Pregnancy and Risk of Early Life Infections in 3 Nordic Cohorts: A HEDIMED Consortium Study.

Journal: The Journal of nutrition

Published: December 29, 2025

Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial.

Safety and Immunogenicity of a Vaccine Against Coxsackieviruses B (PRV-101)-Follow-up of the First-in-Human Phase 1 Trial.

Journal: Open forum infectious diseases

Published: June 03, 2025

Association of fever and infections with the subsequent risk of atopic diseases in children with genetic susceptibility for T1D: Results from the TEDDY cohort study.

Association of fever and infections with the subsequent risk of atopic diseases in children with genetic susceptibility for T1D: Results from the TEDDY cohort study.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: February 05, 2025

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial.

Journal: Diabetologia

Published: September 18, 2023

Assessment of Enterovirus Antibodies during Early Childhood Using a Multiplex Immunoassay.

Assessment of Enterovirus Antibodies during Early Childhood Using a Multiplex Immunoassay.

Journal: Microbiology spectrum

Published: May 25, 2023

HLA-DQ-conferred risk for type 1 diabetes does not alter neutralizing antibody response to a widely used enterovirus vaccine, the poliovirus vaccine.

HLA-DQ-conferred risk for type 1 diabetes does not alter neutralizing antibody response to a widely used enterovirus vaccine, the poliovirus vaccine.

Journal: Journal of medical virology

Published: October 31, 2022

Serum 25-hydroxyvitamin D and fatty acids in relation to the risk of microbial infections in children: The TRIGR Divia study.

Serum 25-hydroxyvitamin D and fatty acids in relation to the risk of microbial infections in children: The TRIGR Divia study.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: June 16, 2022

Association of different enteroviruses with atopy and allergic diseases in early childhood.

Association of different enteroviruses with atopy and allergic diseases in early childhood.

Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Published: March 04, 2021

Correction: Saarinen, N.V.V., et al. Multiplexed High-Throughput Serological Assay for Human Enteroviruses. Microorganismis 2020, 8, 963.

Correction: Saarinen, N.V.V., et al. Multiplexed High-Throughput Serological Assay for Human Enteroviruses. Microorganismis 2020, 8, 963.

Journal: Microorganisms

Published: September 10, 2020

Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study.

Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study.

Journal: Frontiers in immunology

Published: September 09, 2020

Land Cover of Early-Life Environment Modulates the Risk of Type 1 Diabetes.

Land Cover of Early-Life Environment Modulates the Risk of Type 1 Diabetes.

Journal: Diabetes care

Published: July 09, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026